Exact Mass: 614.1138688

Exact Mass Matches: 614.1138688

Found 23 metabolites which its exact mass value is equals to given mass value 614.1138688, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fosaprepitant

(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

C23H22F7N4O6P (614.1165126)


Fosaprepitant is only found in individuals that have used or taken this drug. It is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT3-receptor antagonist ondansetron and the corticosteroid ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis.In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing. D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   
   

1-Hydroxycrisamicin A

1-Hydroxycrisamicin A

C32H22O13 (614.1060362000001)


An organic heterotetracyclic compound isolated from the culture broth of Micromonospora sp. SA-246. It exhibits potent antibacterial activity against several Gram-positive bacterial strains.

   
   

Fosaprepitant

(3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid

C23H22F7N4O6P (614.1165126)


D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   
   
   

2-deoxycytidine 5-monophosphate dimer

2-deoxycytidine 5-monophosphate dimer

C18H28N6O14P2 (614.1138688)


A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of 2-deoxycytidine 5-monophosphate.

   

5,6-diamino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4,5-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione

5,6-diamino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4,5-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione

C18H28N6O14P2 (614.1138688)


An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

   

1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-6-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one

1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-6-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one

C18H28N6O14P2 (614.1138688)


An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.

   

(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C32H22O13 (614.1060362000001)


   

7'-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

7'-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

C32H22O13 (614.1060362000001)


   

3,5-dihydroxy-2-{3-hydroxy-4-[2-methoxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]phenyl}-7-methoxychromen-4-one

3,5-dihydroxy-2-{3-hydroxy-4-[2-methoxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]phenyl}-7-methoxychromen-4-one

C32H22O13 (614.1060362000001)


   

17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

C32H22O13 (614.1060362000001)


   

(11s,15s,17s)-4,7-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

(11s,15s,17s)-4,7-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C32H22O13 (614.1060362000001)


   

(1r,10s,11r,15r,17r)-7-hydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3,5,7-triene-2,9,13-trione

(1r,10s,11r,15r,17r)-7-hydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3,5,7-triene-2,9,13-trione

C32H22O13 (614.1060362000001)


   

7'-{[(2s,3s,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

7'-{[(2s,3s,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

C32H22O13 (614.1060362000001)


   

7,17-dihydroxy-5-{7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl}-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

7,17-dihydroxy-5-{7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl}-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C32H22O13 (614.1060362000001)


   

(11s,15s,17s)-17-methyl-5-[(11s,15s,17s)-2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl]-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

(11s,15s,17s)-17-methyl-5-[(11s,15s,17s)-2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl]-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone

C32H22O13 (614.1060362000001)


   

7-hydroxy-5-{7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl}-17-methyl-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3,5,7-triene-2,9,13-trione

7-hydroxy-5-{7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl}-17-methyl-12,16,18-trioxapentacyclo[8.7.1.0¹,¹⁰.0³,⁸.0¹¹,¹⁵]octadeca-3,5,7-triene-2,9,13-trione

C32H22O13 (614.1060362000001)